Xtant Medical Holdings (XTNT) EBT Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.82% |
| Sep 30, 2025 | 25.96% |
| Jun 30, 2025 | 28.90% |
| Mar 31, 2025 | 15.02% |
| Dec 31, 2024 | -14.83% |
| Sep 30, 2024 | -21.74% |
| Jun 30, 2024 | -14.82% |
| Mar 31, 2024 | -9.31% |
| Dec 31, 2023 | 41.98% |
| Sep 30, 2023 | 33.23% |
| Jun 30, 2023 | 15.33% |
| Mar 31, 2023 | 17.03% |
| Dec 31, 2022 | 40.12% |
| Sep 30, 2022 | 22.73% |
| Jun 30, 2022 | 29.41% |
| Mar 31, 2022 | 18.17% |
| Dec 31, 2021 | 11.76% |
| Sep 30, 2021 | 18.93% |
| Jun 30, 2021 | 32.99% |
| Mar 31, 2021 | 74.14% |
| Dec 31, 2020 | 41.34% |
| Sep 30, 2020 | 28.18% |
| Jun 30, 2020 | 2.48% |
| Mar 31, 2020 | 4.85% |
| Dec 31, 2019 | 16.73% |
| Sep 30, 2019 | 7.55% |
| Jun 30, 2019 | 7.12% |
| Mar 31, 2019 | -2.38% |
| Dec 31, 2018 | -68.58% |
| Sep 30, 2018 | 6.35% |
| Jun 30, 2018 | -15.04% |
| Mar 31, 2018 | -25.77% |
| Dec 31, 2017 | -42.25% |
| Sep 30, 2017 | -27.52% |
| Jun 30, 2017 | -72.45% |
| Mar 31, 2017 | -41.64% |
| Dec 31, 2016 | -0.41% |
| Sep 30, 2016 | -9.87% |
| Jun 30, 2016 | -65.99% |
| Mar 31, 2016 | -25.03% |
| Dec 31, 2015 | -0.43% |
| Sep 30, 2015 | 5.00% |
| Jun 30, 2015 | -6.17% |